London WB - Search Results

1

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

London WB, Bagatell R, Weigel BJ, Fox E, Guo D, Van Ryn C, Naranjo A, Park JR. London WB, et al. Cancer. 2017 Dec 15;123(24):4914-4923. doi: 10.1002/cncr.30934. Epub 2017 Sep 8. Cancer. 2017. PMID: 28885700 Free PMC article. Review.

2

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.

Kretschmar CS, Kletzel M, Murray K, Thorner P, Joshi V, Marcus R, Smith EI, London WB, Castleberry R. Kretschmar CS, et al. Among authors: london wb. J Clin Oncol. 2004 Oct 15;22(20):4119-26. doi: 10.1200/JCO.2004.08.174. J Clin Oncol. 2004. PMID: 15483021 Clinical Trial.

3

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

Rodriguez-Galindo C, Wofford M, Castleberry RP, Swanson GP, London WB, Fontanesi J, Pappo AS, Douglass EC. Rodriguez-Galindo C, et al. Among authors: london wb. Cancer. 2005 Feb 15;103(4):850-7. doi: 10.1002/cncr.20823. Cancer. 2005. PMID: 15641027 Free article. Clinical Trial.

4

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

Norris MD, Smith J, Tanabe K, Tobin P, Flemming C, Scheffer GL, Wielinga P, Cohn SL, London WB, Marshall GM, Allen JD, Haber M. Norris MD, et al. Among authors: london wb. Mol Cancer Ther. 2005 Apr;4(4):547-53. doi: 10.1158/1535-7163.MCT-04-0161. Mol Cancer Ther. 2005. PMID: 15827327

5

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.

Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA; Children's Oncology Group. Marina N, et al. Among authors: london wb. Cancer. 2005 Aug 15;104(4):841-7. doi: 10.1002/cncr.21218. Cancer. 2005. PMID: 15999362 Free article.

6

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.

London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B. London WB, et al. Cancer Lett. 2005 Oct 18;228(1-2):257-66. doi: 10.1016/j.canlet.2004.12.054. Cancer Lett. 2005. PMID: 16024170 Review.

7

Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT. George RE, et al. Among authors: london wb. J Clin Oncol. 2005 Sep 20;23(27):6466-73. doi: 10.1200/JCO.2005.05.582. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116152 Clinical Trial.

8

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. London WB, et al. J Clin Oncol. 2005 Sep 20;23(27):6459-65. doi: 10.1200/JCO.2005.05.571. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116153

9

One- and two-stage designs for stratified phase II clinical trials.

London WB, Chang MN. London WB, et al. Stat Med. 2005 Sep 15;24(17):2597-611. doi: 10.1002/sim.2139. Stat Med. 2005. PMID: 16118809

10

Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.

Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR; Children's Oncology Group. Tebbi CK, et al. Among authors: london wb. Pediatr Blood Cancer. 2006 Feb;46(2):198-202. doi: 10.1002/pbc.20546. Pediatr Blood Cancer. 2006. PMID: 16136581 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page